Success Story: Turning Clinical Data Into Usable Evidence: NIW Approval for a Chinese Biomedical Informatics Specialist
Client’s Testimonial:
“My NIW case was approved after 5 months. I didn't have a strong background, as I have only 5 articles, along with fewer than 20 citations. I do have a software invention, though. After evaluating my case in early January, Victoria said my case should not be difficult and was entitled to the North America Immigration Law Group (NAILG)'s "Approval or Refund" service, which was, to my surprise. Plus, NAILG charged an extremely low attorney fee for their quality service. To be honest, from the consumers' perspective, we usually believe that the higher a service fee for such a credence good is charged, the more likely we are to receive the best expert service. However, unlike other immigration law groups, this is not NAILG's philosophy; instead, NAILG charges the lowest attorney fee but provides the best service.
One more anecdote to share. NAILG had to arrange a new attorney to handle my case, as the original one left the group, but I didn't notice this until they told me. Most importantly, this change of attorneys didn't affect my case's preparation at all. Kudos to NAILG for their outstanding service. In particular, I would like to thank the attorney handling my case. Thank you so much for your hard work!”
On November 16th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Statistical Data Analyst in the field of Biomedical Informatics (Approval Notice).
General Field: Biomedical Informatics
Position at the Time of Case Filing: Statistical Data Analyst
Country of Origin: China
Approval Notice Date: November 16th, 2022
Processing Time: 5 months, 1 day
Case Summary:
Innovation in healthcare increasingly depends on data that can move quickly, reliably, and at scale. For one biomedical informatics specialist, the challenge has been turning complex biomedical information into usable, computable resources that can accelerate basic medical research and precision medicine. That vision ultimately led to a successful EB-2 National Interest Waiver (NIW) approval, secured with the guidance of NAILG (North America Immigration Law Group).
Working in biomedical informatics, the client developed a proposed endeavor focused on continuing research to develop state-of-the-art biomedical informatics tools and services. His work aims to make biomedical data more searchable, interpretable, and analyzable, so that research teams and clinicians can extract meaningful patterns from large and often fragmented datasets. In practical terms, this kind of tool-building helps bridge the gap between specialized medical records and the computational methods used in modern precision medicine.
His work attracted support from two institutes within the National Institutes of Health: the National Library of Medicine and the National Cancer Institute. That funding reinforced the national importance of the client’s direction and its alignment with U.S. priorities in biomedical research infrastructure, cancer-focused advancement, and data-driven medicine.
Beyond funding, the record showed a developing body of scholarly work and field engagement. The client authored 5 peer-reviewed journal articles, and his publications have been cited 19 times, reflecting growing attention from independent researchers. Recognition of expertise also extended beyond authorship. The client was invited to serve as a peer reviewer, completing at least 2 manuscript reviews.
Independent experts underscored the real-world relevance of the client’s work in clinical settings. One recommender noted: "Undoubtedly, [Client]'s research and development of new technologies bring about the advancement of cancer diagnostics. His contributions will benefit clinicians and the care and management of cancer patients."
Through NAILG’s strategic framing of the evidence and careful alignment with the Dhanasar framework, the petition demonstrated that the client’s work carries substantial merit, national importance, and clear benefit to the United States without requiring a permanent job offer. The NIW approval allowed the client to continue advancing biomedical informatics tools that support basic research and precision medicine in the United States.